Citation only
via OpenAlex
Honey, I shrunk the telomere: UC speeds aging
Yuriko Mori, Stephen J. Meltzer
Inflammatory Bowel Diseases · 2009 · ▲ 4 citations
Genomic instability
Telomere attrition
Epigenetic alterations
Cellular senescence
Chronic inflammation
Human
Abstract
Risques RA, Lai LA, Brentnall TA, et al. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere(definition) attrition and DNA damage. Gastroenterology. 2008;135:410–418. In this study, 3 experiments were performed to investigate telomere length and oxidative damage in the nonneoplastic colon of ulcerative colitis (UC) patients and the association of this parameter with age and inflammation. The first experiment analyzed telomere length in colonic biopsies from 85 UC patients and 79 noninflammatory, nonneoplastic control subjects using real-time quantitative polymerase chain reaction (PCR). Colonocyte telomere length significantly decreased with age until it reached a critical length in both UCs and controls, but the decrease in UCs occurred faster than in controls: telomeres shortened to a critical length at age 33 (UCs) versus 59 (controls; P = 0.005). Colonocyte telomere length in UC was dependent on disease duration, and extensive shortening occurred within the first 8.5 years of illness. Late-onset UCs demonstrated prominent telomere shortening regardless of disease duration. Colonic stromal cell telomere shortening did not differ between UCs and controls. The second experiment analyzed telomere length in peripheral blood leukocytes from 102 UCs and 45 controls. Leukocyte telomere length shortened with age in both UCs and controls. The difference between UCs and controls was small but significant (P = 0.043). The third experiment analyzed paraffin-embedded colonic crypt foci from 43 UCs and 53 controls for oxidative damage and telomere length using immunohistochemical quantification of a phosphorylated histone (gH2AX) and a quantitative fluorescent in situ hybridization assay for telomeres, respectively. gH2AX levels in controls increased with age up to age 69, then decreased. gH2AX levels in controls were also inversely correlated with telomere length. In contrast, gH2AX levels in UCs were not correlated with age or telomere length, despite being significantly higher than those in controls up to the age of 59 years (P < 0.05). In summary, colonocyte telomere length shortened with age, and this shortening was markedly accelerated in UC, especially during the first 8 years of illness. Weak or absent telomere shortening acceleration in leukocytes and stromal cells implied that epithelial cell proliferation promoted by inflammation was responsible for this acceleration. Oxidative damage accumulated in UC colonocytes independent of aging or telomere shortening. Colonocytic premature aging appeared to characterize UC, which may explain its higher and earlier cancer risk. UC patients are predisposed to colorectal cancer (CRC), although the risk relative to the general population was recently reported to have decreased.1,2 CRC risk is especially high in UC patients with pancolitis or long disease duration, which implies that inflammation itself promotes UC tumorigenesis.3 Many authors consider that inflammation reinforces or accelerates aging, a major risk factor for sporadic malignancies.4 A putative direct link in UC connecting inflammation, cancer susceptibility, and premature aging is telomere shortening. Telomeres shorten upon cell division and as a consequence of oxidative damage, common features of inflammation.5 Telomere shortening is also linked to both aging-associated disorders and CRC by promoting chromosomal instability (CIN) under a disrupted DNA damage checkpoint and by attenuating DNA damage repair.5 Interestingly, activated neutrophils can impair the DNA damage repair system of UC colonocytes.6 The current article supports the hypothesis that telomere shortening in UC is the result of premature colonocyte aging, utilizing an experimental data-based mathematical model. The strength of this work is the well-fitted model of age-associated telomere shortening in normal colonocytes generated from a cohort containing multiple young individuals, which was previously unavailable.7,8 This model established a firm basis for their analysis of aberrancy in UC within the context of colonocyte aging. However, their model correlating UC duration and telomere shortening may be even further improved by excluding late-onset UCs, whose telomeres reached critical length prior to the onset of UC as a result of normal aging. The authors have already reported frequent CIN and its correlation with telomere shortening in nonneoplastic colonocytes from UC patients with CRC or dysplasia.9,10 Thus, taken together with these previous data, they present an attractive model for early carcinogenesis in UC. A few questions were left open and deserve future investigation: 1) Sufficient evidence was not provided to directly connect telomere shortening to persistent inflammation in colonocytes and, ultimately, to carcinogenesis unique to inflammatory crypt foci, because all but 1 in the UC cohort had pancolitis. Similarly, as the authors noted, it will be important to correlate the presence of inflammation, telomere length, and CIN with other factors affecting the DNA damage checkpoint (e.g., p53 and p16). 2) Insights are needed into factors that produce the observed large variances in telomere length among UC cases under 30 years old and among early-onset UC cases whose disease duration is shorter than a decade. Activation of telomerase has been reported in UC, which could be a contributing factor to this variance.11 3) Insights are needed into the cause and outcome of the marked gH2AX accumulation in UC and into its potential role in UC carcinogenesis. Nevertheless, the current data constitute strong evidence in support of premature aging in UC, which follows a previous report based on another known epigenetic mark, aging-associated DNA hypermethylation.12 Now, an interesting question arises from these data: Can anti-aging treatment benefit UC patients?
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/ibd.20887
- Canonical
- link ↗
- Fetched
- 2026-10-04 MST
Cite this
APA
Mori, Y., & Meltzer, S.J. (2009). Honey, I shrunk the telomere: UC speeds aging. <em>Inflammatory Bowel Diseases</em>. https://doi.org/10.1002/ibd.20887
Vancouver
Mori Y, Meltzer SJ. Honey, I shrunk the telomere: UC speeds aging. Inflammatory Bowel Diseases. 2009. doi:10.1002/ibd.20887.
BibTeX
@article{yuriko2009HoneyI,
title = {Honey, I shrunk the telomere: UC speeds aging},
author = {Yuriko Mori and Stephen J. Meltzer},
journal = {Inflammatory Bowel Diseases},
year = {2009},
doi = {10.1002/ibd.20887},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Medicine 2020
Open access · CC-BY
Increased Sensitivity of PBMCs Isolated from Patients with Rheumatoid Arthritis to DNA Damaging Agents Is Connected with Inefficient DNA Repair
eLife 2021
Open access · CC-BY
DNA damage—how and why we age?
Translational Neurodegeneration 2023
Open access · CC-BY
Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases
Biological Psychiatry 2011
Open access · CC-BY
Hostility and Cellular Aging in Men from the Whitehall II Cohort
Current Aging Science 2010
Citation only
DNA Repair in Premature Aging Disorders and Neurodegeneration
International Journal of Molecular Sciences 2013
Open access · CC-BY